2017 Annual Meeting | STC3 - Section Topic Controversies: Chemo Brain: Neuro-cognitive Impact of Anti-cancer Therapies

Date Thursday 04/27/17

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Highlights in the Field/Section Topic Controversies

Topic(s) Neuro-oncology

CME Available 0.00 credit

Event Timeline
No timeline events available at this time.

Faculty Disclosures
Jorg Dietrich, MD, PhD, FAAN	Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.

��ɫ����